Authors:
DECENSI A
BONANNI BD
GUERRIERIGONZAGA A
GANDINI S
ROBERTSON C
JOHANSSON H
TRAVAGLINI R
SANDRI MT
TESSADRELLI A
FARANTE G
SALINARO F
BETTEGA D
BARRECA A
BOYLE P
COSTA A
VERONESI U
Citation: A. Decensi et al., BIOLOGIC ACTIVITY OF TAMOXIFEN AT LOW-DOSES IN HEALTHY WOMEN, Journal of the National Cancer Institute, 90(19), 1998, pp. 1461-1467
Authors:
DECENSI A
TORRISI R
FONTANA V
BARRECA A
PONZANI P
PENSA F
PARODI S
COSTA A
Citation: A. Decensi et al., CORRELATION BETWEEN PLASMA TRANSFORMING GROWTH-FACTOR-BETA-1 AND 2ND PRIMARY BREAST-CANCER IN A CHEMOPREVENTION TRIAL, European journal of cancer, 34(7), 1998, pp. 999-1003
Authors:
TORRISI R
PARODI S
FONTANA V
PENSA F
CASELLA C
BARRECA A
DEPALO G
COSTA A
DECENSI A
Citation: R. Torrisi et al., EFFECT OF FENRETINIDE ON PLASMA IGF-I AND IGFBP-3 IN EARLY BREAST-CANCER PATIENTS, International journal of cancer, 76(6), 1998, pp. 787-790
Authors:
DECENSI A
ROBERTSON C
ROTMENSZ N
SEVERI G
MAISONNEUVE P
SACCHINI V
BOYLE P
COSTA A
VERONESI U
Citation: A. Decensi et al., EFFECTS OF TAMOXIFEN AND TRANSDERMAL HORMONE REPLACEMENT THERAPY ON CARDIOVASCULAR RISK-FACTORS IN A PREVENTION TRIAL, British Journal of Cancer, 78(5), 1998, pp. 572-578
Authors:
FAVONI RE
DECUPIS A
BRUNO S
YEE D
FERRERA A
PIRANI P
COSTA A
DECENSI A
Citation: Re. Favoni et al., MODULATION OF THE INSULIN-LIKE GROWTH-FACTOR-I SYSTEM BY N-(4-HYDROXYPHENYL)-RETINAMIDE IN HUMAN BREAST-CANCER CELL-LINES, British Journal of Cancer, 77(12), 1998, pp. 2138-2147
Authors:
DEPALO G
CAMERINI T
MARUBINI E
COSTA A
FORMELLI F
DELVECCHIO M
MARIANI L
MICELI R
MASCOTTI G
MAGNI A
CAMPA T
DIMAURO MG
ATTILI A
MALTONI C
DELTURCO MR
DECENSI A
DAIUTO G
VERONESI U
Citation: G. Depalo et al., CHEMOPREVENTION TRIAL OF CONTRALATERAL BREAST-CANCER WITH FENRETINIDE- RATIONALE, DESIGN, METHODOLOGY, ORGANIZATION, DATA MANAGEMENT, STATISTICS AND ACCRUAL, Tumori, 83(6), 1997, pp. 884-894
Authors:
BRUNO S
MACHI AM
SEMINO C
META M
PONTE M
VARALDO M
CUROTTO A
FERLAZZO G
DECENSI A
MELIOLI G
Citation: S. Bruno et al., PHENOTYPIC, FUNCTIONAL AND MOLECULAR ANALYSIS OF LYMPHOCYTES ASSOCIATED WITH BLADDER-CANCER, Cancer immunology and immunotherapy, 42(1), 1996, pp. 47-54
Authors:
TORRISI R
PENSA F
FONTANA V
COSTA A
DECENSI A
Citation: R. Torrisi et al., THE METABOLITE N-4-METHOXYPHENYLRETINAMIDE IS A MAJOR DETERMINANT OF FENRETINIDE INDUCED DECLINE OF PLASMA INSULIN-LIKE GROWTH-FACTOR-I, European journal of cancer, 31A(3), 1995, pp. 420-421
Authors:
PONZONI M
BOCCA P
CHIESA V
DECENSI A
PISTOIA V
RAFFAGHELLO L
ROZZO C
MONTALDO PG
Citation: M. Ponzoni et al., DIFFERENTIAL-EFFECTS OF N-(4-HYDROXYPHENYL)RETINAMIDE AND RETINOIC ACID ON NEUROBLASTOMA-CELLS - APOPTOSIS VERSUS DIFFERENTIATION, Cancer research, 55(4), 1995, pp. 853-861
Authors:
DECENSI A
TORRISI R
POLIZZI A
GESI R
BREZZO V
ROLANDO M
RONDANINA G
ORENGO MA
FORMELLI F
COSTA A
Citation: A. Decensi et al., EFFECT OF THE SYNTHETIC RETINOID FENRETINIDE ON DARK-ADAPTATION AND THE OCULAR SURFACE, Journal of the National Cancer Institute, 86(2), 1994, pp. 105-110
Authors:
DECENSI A
BRUNO S
COSTANTINI M
TORRISI R
CUROTTO A
GATTESCHI B
NICOLO G
POLIZZI A
PERLOFF M
MALONE WF
BRUZZI P
Citation: A. Decensi et al., PHASE-IIA STUDY OF FENRETINIDE IN SUPERFICIAL BLADDER-CANCER, USING DNA FLOW-CYTOMETRY AS AN INTERMEDIATE END-POINT, Journal of the National Cancer Institute, 86(2), 1994, pp. 138-140
Authors:
TORRISO R
PARODI S
FONTANA V
RONDANINA G
FORMELLI F
COSTA A
BOCCARDO F
DECENSI A
Citation: R. Torriso et al., FACTORS AFFECTING PLASMA RETINOL DECLINE DURING LONG-TERM ADMINISTRATION OF THE SYNTHETIC RETINOID FENRETINIDE IN BREAST-CANCER PATIENTS, Cancer epidemiology, biomarkers & prevention, 3(6), 1994, pp. 507-510
Authors:
DECENSI A
BRUNO S
TORRISI R
PARODI S
POLIZZI A
Citation: A. Decensi et al., PILOT-STUDY OF HIGH-DOSE FENRETINIDE AND VITAMIN-A SUPPLEMENTATION INBLADDER-CANCER, European journal of cancer, 30A(12), 1994, pp. 1909-1910